| Drug Name |
Description of Change |
Cost-effective Alternatives |
| Alrex 0.2% eye drops |
No longer covered |
loteprednol 0.2% eye drops |
| Emflaza tablets |
No longer covered |
deflazacort tablets |
| Forteo 600 mcg/2.4 mL pens |
No longer covered |
teriparatide 600 mcg/2.4 mL pens |
| Rectiv 0.4% ointment |
No longer covered |
nitroglycerin 0.4% ointment |
| Risperdal Consta vials |
No longer covered |
risperidone extended-release vials |